project id: TCGA-BLCA; case submitter id: TCGA-C4-A0F0; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.9; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22068; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1947; age at diagnosis: 22068; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 59.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 3.3424657534246576; pack years smoked: 61.0; is ffpe: false; composition: Not Reported; days to collection: 1207; days to sample procurement: 0; initial weight: 380.0; portion submitter id: TCGA-C4-A0F0-01A-12; percent necrosis: 20.0; percent stromal cells: 0.0;